There are no medications available in the U.S. for treating stress urinary incontinence. Findings from a new Cleveland Clinic study suggest a muscle growth promoter may be a pharmaceutical option.
Concurrent urogynecologic and hemorrhoid surgery is safe but patients should be counseled carefully to expect minor adverse events such as urinary tract infections.
Connect with our staff in the following sessions at the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction 2019 Winter Meeting.
Cleveland Clinic researchers have found that intraperitoneally injected mesenchymal stem cells home to pelvic organs in an animal model of pelvic organ prolapse (POP) after simulated childbirth delivery, confirming that tissue injury plays a role in the homing of these cells. The results could be relevant for future stem cell-based therapies for delivery-related disorders such as POP.